Authors:
Zinzani, PL
Martelli, M
De Renzo, A
Zaccaria, A
Pavone, E
Bocchia, M
Falini, B
Gobbi, M
Gherlinzoni, F
Bendandi, M
Stefoni, V
Tani, M
Tura, S
Citation: Pl. Zinzani et al., Primary mediastinal large B-cell lymphoma with sclerosis: a clinical studyof 89 patients treated with MACOP-B chemotherapy and radiation therapy, HAEMATOLOG, 86(2), 2001, pp. 187-191
Authors:
Pace, L
Catalano, L
Del Vecchio, S
Di Gennaro, F
De Renzo, A
Sica, G
Califano, C
Tedesco, N
Borrelli, G
Rotoli, B
Salvatore, M
Citation: L. Pace et al., Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up, EUR J NUCL, 28(3), 2001, pp. 304-312
Authors:
Zinzani, PL
Magagnoli, M
Moretti, L
De Renzo, A
Battista, R
Zaccaria, A
Guardigni, L
Mazza, P
Marra, R
Ronconi, F
Lauta, VM
Bendandi, M
Gherlinzoni, F
Gentilini, P
Ciccone, F
Cellini, C
Stefoni, V
Ricciuti, F
Gobbi, M
Tura, S
Citation: Pl. Zinzani et al., Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma, J CL ONCOL, 18(4), 2000, pp. 773-779
Authors:
Zinzani, PL
Martelli, M
Magagnoli, M
Zaja, F
Storti, S
Pavone, E
Lauta, VM
De Renzo, A
Gobbi, M
Bocchia, M
Ronconi, F
Scaramucci, L
Gherlinzoni, F
Palombi, F
Bendandi, M
Stefoni, V
Borza, PA
Cellini, C
Mandelli, F
Tura, S
Citation: Pl. Zinzani et al., How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens fare in the long-term?, HAEMATOLOG, 84(11), 1999, pp. 996-1001
Authors:
Zinzani, PL
Magagnoli, M
Moretti, L
Battista, R
Ronconi, F
De Renzo, A
Zaccaria, A
Gentilini, P
Guardigni, L
Gherlinzoni, F
Cellini, C
Fattori, PP
Bendandi, M
Bocchia, M
Aitini, E
Tura, S
Citation: Pl. Zinzani et al., Fludarabine based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients, HAEMATOLOG, 84(11), 1999, pp. 1002-1006
Authors:
De Renzo, A
Santoro, LFE
Notaro, R
Pane, F
Buonaiuto, MR
Luciano, L
Rotoli, B
Citation: A. De Renzo et al., Acute promyelocytic leukemia after treatment for non-Hodgkin's lymphoma with drugs targeting topoisomerase II, AM J HEMAT, 60(4), 1999, pp. 300-304
Authors:
Zinzani, PL
Storti, S
Zaccaria, A
Moretti, L
Magagnoli, M
Pavone, E
Gentilini, P
Guardigni, L
Gobbi, M
Fattori, PP
Falini, B
Lauta, VM
Bendandi, M
Gherlinzoni, F
De Renzo, A
Zaja, F
Mazza, P
Volpe, E
Bocchia, M
Aitini, E
Tabanelli, M
Leone, G
Tura, S
Citation: Pl. Zinzani et al., Elderly aggressive-histology non-Hodgkin's lymphoma: First-line VNCOP-B regimen experience on 350 patients, BLOOD, 94(1), 1999, pp. 33-38